Back to search
FDAFDA · Food and drugs·Recall number D-1516-201

Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01

Published September 28, 2016 · Recall initiated: March 24, 2016

Summary

FDA records drug Class III recall D-1516-201, published September 28, 2016 and initiated March 24, 2016. Recalling firm: Lupin Limited; Status: Terminated; Reported quantity: 3,192 bottles (319,200 tablets); Lot: Lot # G510086; Exp. 11/17. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Lot and/or Expiration Date

What to do

Voluntary: Firm initiated · E-Mail

Get an email if ESCITALOPRAM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ESCITALOPRAM
Manufacturer
Lupin Limited
Distributor
Nationwide
UPC
0368180135012
Lot
Lot # G510086; Exp. 11/17
Risk classification
Class III
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01 recalled?

Yes. FDA published recall D-1516-201 on September 28, 2016. Reported hazard: Labeling: Incorrect or Missing Lot and/or Expiration Date

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ESCITALOPRAM. UPC: 0368180135012.